Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
Neurology|June 1, 1996
Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study GroupE Faught, B J Wilder, R E Ramsay, et al.International Journal of Sports Physiology and Performance|December 15, 2016
Peak Running Intensity of International Rugby: Implications for Training PrescriptionJace A Delaney, Heidi R Thornton, John F Pryor, et al.Epilepsia|May 1, 1994
Vagus nerve stimulation for treatment of partial seizures: 2. Safety, side effects, and tolerability. First International Vagus Nerve Stimulation Study GroupR E Ramsay, B M Uthman, L E Augustinsson, et al.Epilepsy Research|October 23, 1997
Intramuscular fosphenytoin (Cerebyx) in patients requiring a loading dose of phenytoinR E Ramsay, B J Wilder, B M Uthman, et al.Neurology|May 30, 2008
Trends in antiepileptic drug prescribing for older patients with new-onset epilepsy: 2000-2004M J V Pugh, A C Van Cott, J A Cramer, et al.Epilepsy Research|March 1, 1995
Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizuresE Ben-Menachem, A Hamberger, T Hedner, et al.Neurology|July 1, 1993
Treatment of epilepsy by stimulation of the vagus nerveB M Uthman, B J Wilder, J K Penry, et al.Epilepsia|January 1, 1994
Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trialJ Messenheimer, R E Ramsay, L J Willmore, et al.Archives of Internal Medicine|December 22, 1999
Guidelines for nonemergency use of parenteral phenytoin products: proceedings of an expert panel consensus process. Panel on Nonemergency Use of Parenteral Phenytoin ProductsP D Meek, S N Davis, D M Collins, et al.Neurology|April 1, 1993
Felbamate monotherapy for partial-onset seizures: an active-control trialE Faught, R C Sachdeo, M P Remler, et al.Pageof 8